november9san diego poster correctio october 26

1
HIV induces complement C3 in primary human astrocytes indirectly through a NFkB-dependent pathway Jadwiga Nitkiewicz, Wei Chao, Seon-Young Kim, Luni Nemdad, Devanand Sarkar, Paul Fisher and David J. Volsky Molecular Virology Division, St. Lukes-Roosevelt Hospital Center, and Department of Pathology Columbia University Medical Center, New York, NY 10019 important role in protecting brain against HIV infection and development of HIV-associated dementia (HAD). Complement C3 is a key component dels of other neurodegenerative diseases such as multiple sclerosis, uncontrolled C3 production can lead to tissue injury and inflammation. the brain including astrocytes. We and others have previously shown that HIV interaction with astrocytes in vitro alters cellular gene disrupts important physiological functions of the cells such as glutamate transport. 3 induction in human fetal astrocytes (HFA) exposed to HIV in vitro. Using transient transfection assays with a C3 promoter-driven indicator und that exposure of astrocytes to HIV increased C3 promoter production, indicating that HIV acts by transcriptional activation of the C3 gene. revealed that activation of C3 by HIV requires, among others, the NFkB and PTK signaling pathways; however, surprisingly, the C3 core s. Activation of the C3 promoter by HIV was absolutely dependent on the presence of the interleukin 1-beta/interleukin 6 responsive element to -100. The requirement for functional NFkB for HIV effect on C3 was confirmed by overexpresion of the NFkB inhibitor IkB-a in astrocytes; -a into HFA, but not of control virus, blocked nuclear translocation of NFkB and prevented induction of C3 promoter and mRNA. 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 C 3 P ro m o te r A ct (R LU ,FC ) 48h 0 50 100 150 200 250 300 C 3 P ro tein (ng/ 3d 7d 0 1 2 3 4 5 6 7 8 m R N A (F o ld Cha 24h 7d 0 20 40 60 80 100 120 140 160 C 3 Prom oterActivity (RLU) 48h 0 5 10 15 20 25 30 35 40 45 50 C3 Prom oterActivity (RLU) 48h 0 2 4 6 8 10 12 14 16 18 C3 m RNA (Fold Change) 24h 3d FIGURE 2A, B EFFECT OF PHARMACOLOGICAL INHIBITORS OF SIGNAL TRANSDUCTION PATHWAY ON C3 PROMOTER INDUCTION BY HIV IN ASTROCYTES FIGURE 2C EFFECT OF INHIBITORS OF NFKAPPA B (CAPE) and PTK (GENISTEIN) ON C3 GENE EXPRESSION AFTER HIV EXPOSURE OF PRIMARY ASTROCYTES FIGURE 1 A. DETECTION OF C3 PROTEIN SECRETION IN CELL SUPERNATANTS B. C3 GENE EXPRESSION IN EARLY (24H), AND LATE (7 D) TIMEPOINT TESTED IN CELL EXTRACT C. INDUCTION OF C3 PROMOTER AFTER 48H; TESTED IN CELL EXTRACT FIGURE 3A DETECTION OF p50 SUBUNITS OF ACTIVATED NFkappaBIN NUCLEAR EXTRACT (AFTER 30 MIN OF THE HIV EXPOSURE OF PRIMARY ASTROCYTES BY TRANSBINDING TM NFkappaB ASSAY KIT) RPN800 TNFα IL-1β HIV mock medium RPN 756 (0.5, 1pgP24/cell) FIGURE 3B DETECTION OF PYK-2 PROTEIN TYROSINE KINASE IN CELL EXTRACT (BY W-B AFTER 30 MIN OF HIV EXPOSURE OF HFA) ASTROCYTES INFECTED WITH ADENOVIRUS MUTANT MT32IkB (2HR PRIOR HIV EXPOSURE) FIGURE 5 A, B, C Cell- medium Cell- Mock Cell- IL1 Cell- HIV Ad.vec- medium Ad.vec- IL1 Ad.vec- HIV Ad.vec- Mock Ad.IB-mt32- medium Ad.IB-mt32 - Mock Ad.IB-mt32 -HIV Ad.IB-mt32 -IL1 IMMUNOSTAINING FOR DETECTION OF p65 SUBUNITS ACTIVATED NFkappaB (images from Confocal Laser Scanning Microscope LSM multiphoton 510) 0 50 100 150 200 250 R elative Luciferase A ctivity [R LU ] 48h 0 20 40 60 80 C1/HIV C1 C2/HIV C2 C3/HIV C3 C4/HIV C4 C5/HIV C5 C6/HIV C6 CF/HIV CF Relative Luciferase Activity (RLU) LUC LUC LUC LUC LUC LUC LUC X X X X X FIGURE 4A THE DELETION ANALYSIS OF C3 PROMOTER REGION IN HIV RESPONSE OF PRIMARY ASTROCYTES FIGURE 4B THE MUTATION ANALYSIS OF C3 PROMOTER IN HIV RESPONSE 1. mutation ‘C1’ –109 -(-90) IL-1/IL-6 2. mutation ‘C2’ –106- (-100) ‘IL6’ 3. mutation ‘C3’ – 116 – (-100) ‘IFN- gamma’ 4. mutation ‘C4’ – 181- (-175) ‘IL6’ 5. mutation ‘C5’ –615 – (-604) ‘NFkB 6. mutation’ C6’ –750 – (-740) ‘NFkB’ CONCLUSIONS EXPOSURE OF PRIMARY ASTROCYTES TO HIV INDUCES ACTIVATION of COMPLEMENT C3 PROMOTER, INCREASED C3 mRNA TRANSCRIPTION, and SECRETION of C3 PROTEIN INDUCTION of C3 GENE requires primarily PROLINE RICH PROTEIN TYROSINE KINASE PYK-2 , MAPK signaling pathways, and is NFkappaB dependent; through indirect mechanism- NFkB binding sites in C3 promoter are dispensable for promoter activity CRITICAL RESPONSIVE ELEMENT on C3 PROMOTER in HIV-1 RESPONSE is LOCATED; between NUCLEOTIDES [-109- (90)] with SUBDOMAIN at [ –106- (-100]; and it includes IL1-β, and IL-6 responsive elements X 0 10 20 30 40 50 60 C 3 P ro m o ter A c tiv ity (R 0 0.05 0.1 0.15 0.2 0.25 N uclearp50 (O D 450nm ) INDUCTION OF C3 PROMOTER TESTED IN CELL EXTRACT DETECTION OF p50 SUBUNITS OF ACTIVATED NFkappaB HETERODIMER IN NUCLEAR EXTRACT (30MIN/HIV) FIG 1A FIG 1B FIG 1C FIG 2A FIG 2B FIG 2C FIG 5A FIG 5B FIG 5C 0 0.05 0.1 0.15 0.2 0.25 P ositive control Competitor IL-1 beta HIV m ock medium C ape/HIV C ape/m ock Cape/m edium Nuclearp50 (O D value 450nm )

Upload: j-nitkiewicz

Post on 12-Jan-2017

94 views

Category:

Documents


1 download

TRANSCRIPT

  • HIV induces complement C3 in primary human astrocytes indirectly through a NFkB-dependent pathwayJadwiga Nitkiewicz, Wei Chao, Seon-Young Kim, Luni Nemdad, Devanand Sarkar, Paul Fisher and David J. VolskyMolecular Virology Division, St. Lukes-Roosevelt Hospital Center, and Department of Pathology Columbia University Medical Center, New York, NY 10019INTRODUCTIONInnate immunity is believed to play an important role in protecting brain against HIV infection and development of HIV-associated dementia (HAD). Complement C3 is a key component of the innate immunity system but in models of other neurodegenerative diseases such as multiple sclerosis, uncontrolled C3 production can lead to tissue injury and inflammation. C3 is secreted by several cell types in the brain including astrocytes. We and others have previously shown that HIV interaction with astrocytes in vitro alters cellular gene expression, induces interleukin-6, and disrupts important physiological functions of the cells such as glutamate transport. Here we investigated the mechanism of C3 induction in human fetal astrocytes (HFA) exposed to HIV in vitro. Using transient transfection assays with a C3 promoter-driven indicator gene, real-time PCR, and C3 ELISA we found that exposure of astrocytes to HIV increased C3 promoter activity, mRNA expression, and protein production, indicating that HIV acts by transcriptional activation of the C3 gene. Studies with pharmacological inhibitors revealed that activation of C3 by HIV requires, among others, the NFkB and PTK signaling pathways; however, surprisingly, the C3 core promoter lacks NFkB and SP binding sites. Activation of the C3 promoter by HIV was absolutely dependent on the presence of the interleukin 1-beta/interleukin 6 responsive element at -109 to -90 and its sub-domain -106 to -100. The requirement for functional NFkB for HIV effect on C3 was confirmed by overexpresion of the NFkB inhibitor IkB-a in astrocytes; adenovirus-mediated transduction of IkB-a into HFA, but not of control virus, blocked nuclear translocation of NFkB and prevented induction of C3 promoter and mRNA. FIGURE 2A, BEFFECT OF PHARMACOLOGICAL INHIBITORS OF SIGNAL TRANSDUCTION PATHWAY ON C3 PROMOTER INDUCTION BY HIV IN ASTROCYTESFIGURE 2C EFFECT OF INHIBITORS OF NFKAPPA B (CAPE) and PTK (GENISTEIN) ON C3 GENE EXPRESSION AFTER HIV EXPOSURE OF PRIMARY ASTROCYTESFIGURE 1 A. DETECTION OF C3 PROTEIN SECRETION IN CELL SUPERNATANTS B. C3 GENE EXPRESSION IN EARLY (24H), AND LATE (7 D) TIMEPOINT TESTED IN CELL EXTRACTC. INDUCTION OF C3 PROMOTER AFTER 48H; TESTED IN CELL EXTRACTFIGURE 3A DETECTION OF p50 SUBUNITS OF ACTIVATED NFkappaBIN NUCLEAR EXTRACT (AFTER 30 MIN OF THE HIV EXPOSURE OF PRIMARY ASTROCYTES BY TRANSBINDING TM NFkappaB ASSAY KIT)

    RPN800 TNF IL-1 HIV mock medium RPN 756 (0.5, 1pgP24/cell) FIGURE 3BDETECTION OF PYK-2 PROTEIN TYROSINE KINASE IN CELL EXTRACT (BY W-B AFTER 30 MIN OF HIV EXPOSURE OF HFA)ASTROCYTES INFECTED WITH ADENOVIRUS MUTANT MT32IkB (2HR PRIOR HIV EXPOSURE) FIGURE 5 A, B, CCell-mediumCell-MockCell-IL1Cell-HIVAd.vec-mediumAd.vec-IL1Ad.vec-HIVAd.vec-MockAd.IkBa-mt32-mediumAd.IkBa-mt32 -MockAd.IkBa-mt32 -HIVAd.IkBa-mt32 -IL1IMMUNOSTAINING FOR DETECTION OF p65 SUBUNITS ACTIVATED NFkappaB(images from Confocal Laser Scanning Microscope LSM multiphoton 510)

    LUCLUCLUCLUCLUCLUCLUCXXXXXFIGURE 4A THE DELETION ANALYSIS OF C3 PROMOTER REGION IN HIV RESPONSE OF PRIMARY ASTROCYTES FIGURE 4BTHE MUTATION ANALYSIS OF C3 PROMOTER IN HIV RESPONSE 1. mutation C1 109 -(-90) IL-1/IL-6 2. mutation C2 106- (-100) IL6 3. mutation C3 116 (-100) IFN- gamma 4. mutation C4 181- (-175) IL6 5. mutation C5 615 (-604) NFkB 6. mutation C6 750 (-740) NFkBCONCLUSIONSEXPOSURE OF PRIMARY ASTROCYTES TO HIV

    INDUCES ACTIVATION of COMPLEMENT C3 PROMOTER, INCREASED C3 mRNA TRANSCRIPTION, and SECRETION of C3 PROTEIN

    INDUCTION of C3 GENE requires primarily PROLINE RICH PROTEIN TYROSINE KINASE PYK-2 , MAPK signaling pathways, and is NFkappaB dependent; through indirect mechanism- NFkB binding sites in C3 promoter are dispensable for promoter activity

    CRITICAL RESPONSIVE ELEMENT on C3 PROMOTER in HIV-1 RESPONSE is LOCATED; between NUCLEOTIDES [-109- (90)] with SUBDOMAIN at [ 106- (-100]; and it includes IL1-, and IL-6 responsive elementsXINDUCTION OF C3 PROMOTER TESTED IN CELL EXTRACTDETECTION OF p50 SUBUNITS OF ACTIVATED NFkappaB HETERODIMER IN NUCLEAR EXTRACT (30MIN/HIV)FIG 1AFIG 1BFIG 1CFIG 2AFIG 2BFIG 2CFIG 5AFIG 5BFIG 5C

    Chart1

    1.5333333330.251661148

    1.8750.275

    3.190.69

    0.8750.075

    1.010.01

    48h

    C3 Promoter Activity (RLU, FC)

    inhibitors 2b graph

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    graph cont inhib 2b

    1577.9917269723

    62.52

    113.6055512755

    150.2385979883

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    kontrole do inhib 2b

    HIVmedmock cIL-1TNF-mediummock c

    average31111515762.51115

    25.51316156.5551316

    40.011118158.170.531118

    26.95911156.461.97911

    average30.82111515762.51115

    SD7.991726972323.60555127550.95393920147.778553850223.6055512755

    Ttest0.03534436910.00000031680.0006591335

    IL-1 betaTNF-alfamediummock

    15762.51115

    156.5551316

    158.170.531118

    156.461.97911

    av15762.51115

    SD0.95393920147.778553850223.6055512755

    0.0006591335

    inhibitors2b

    HIVIL-1 betaTNF- alfamediummockCape/HIVCape/mediumPDTC/HIVPDTC/mediumAG18/HIVAG18/mediumU126/HIVU126/mediumWortmanin/HIVWortmanin/mediumSQ-22536/HIVSQ-22536/mediumCalphostin/HIVCalphostin/medium

    3115762.5111533.61311.51111.43733382137.6302825

    7.99172697230.95393920147.778553850223.60555127550.23859798830.35694257240.16165807540.50.88573886292.11660104890.71103650870.41508031355.36055967230.86694867214.89672339434.43030472996.55743852432.6457513111

    19-Jul

    HIVmediummockCape/HIVCape/mediumPDTC/HIVPDTC/mediumAG18/HIVAG18/mediumU126/HIVU126/mediumCalphostin/HIVCalphostin/medium

    av31111533.61311.51111.437332825

    SD7.991726972323.60555127550.23859798830.35694257240.16165807540.50.88573886292.11660104890.71103650870.41508031356.55743852432.6457513111

    controle do graph inhib2b wl

    controle do graph inhib2b wl

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wl graph 1 Elisa p50NFkB

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    graphknock 5000vpC3 prom

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wlgraph knockout Il1 Il6 5000vp

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    knockout Il1, Il6 5000vp

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    knockout5000Il1,Il6

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wl graph ad 5000 C3 prom bz Il1

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    daneknockout 5000vp promotor C3

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    1 EL p50NFkB

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    EL p50 controls

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    mC3RNA 24h, 3d signal transd

    mC3RNA 24h, 3d signal transd

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    inhib2A wlasc grapg bez Il1

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    graph Inhib 2A bez Il1

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    inhibitors 2A

    inhibitors 2A

    1312

    451.5275252317

    222.5166114784

    20.61.443375673

    9.90.1

    5.30.1527525232

    6.20.2645751311

    4.180.2306512519

    124.31.5275252317

    461

    6.80.3511884584

    6.30.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    grph C3 protein1

    1312

    451.5275252317

    222.5166114784

    20.61.443375673

    9.90.1

    5.30.1527525232

    6.20.2645751311

    4.180.2306512519

    124.31.5275252317

    461

    6.80.3511884584

    6.30.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    daneC3 proteina

    1312

    451.5275252317

    222.5166114784

    20.61.443375673

    9.90.1

    5.30.1527525232

    6.20.2645751311

    4.180.2306512519

    124.31.5275252317

    461

    6.80.3511884584

    6.30.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    Q-PCR 24, 7ddane

    Exp 02/05IL-1 beta 1ng/ml][20ng/ml]Ad-IkB/IL-1Ad-IkB/IL-6Ad-IkB/mockAdenovirusAd/mockAd/IL-1

    Br52/2

    systemIL-1 betaIL-6mockmediumAd-IkB/IL-1Ad-IkB/IL-6Ad-IkB/mockAdenovirus-IkB/mediumAd/IL-1Ad/IL-6Ad/mockAdenovirus/medium

    average131452220.69.95.36.24.18124.3466.86.3

    11314422219.75.56.63.94125457.26.5

    2129471918.59.55.36.14.4126476.86.3

    31334624219.65.26.54.2123466.56.1

    average13145.666666666722.2520.6259.65.33333333336.44.18124.6666666667466.83333333336.3

    SD21.52752523172.51661147841.4433756730.10.15275252320.26457513110.23065125191.527525231710.35118845840.2

    Ttest

    Ad-IkB/mockAdenovirus-IkBAdenovirusAd/mockAd/IL-1Ad/IL-6

    6.97.1124.346

    Ad-IkB/mockAdenovirus-IkB/medium6.57.212545

    6.24.256.36.812647

    6.63.946.16.512346

    6.14.46.36.8333333333124.666666666746

    6.54.20.20.35118845841.52752523171

    6.44.18

    0.26457513110.2306512519

    Q-PCR 24, 7ddane

    1262

    451.5275252317

    242.5166114784

    221.443375673

    9.90.1

    5.70.1527525232

    4.250.2306512519

    6.20.2645751311

    6.90.2

    7.10.3511884584

    124.31.5275252317

    461

    5000vp/cell

    cell extract

    Relative Luciferase Activity [RLU]

    wykresy Q-PCR mRNA24, 7d

    wykresy Q-PCR mRNA24, 7d

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wl wykr C3 promoter

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wykr promoter C3 ind

    Exp 02/05Ad 5000vp/cellAd-IkB/mockAd-IkB/HIV

    Br52/2Adenovirus-IkB

    systemHIV+mockmediumAdenovirus-IkBAd-IkB/mockAd-IkB/HIVAdenovirusAd/mockAd/HIV+

    average4724224.256.24.96.97.138.3

    14822213.946.64.76.57.236

    2491918.54.46.14.96.36.837

    34624214.26.54.66.16.539

    average47.522.2520.6254.186.44.73333333336.36.833333333337.3333333333

    SD1.52752523172.51661147841.4433756730.23065125190.26457513110.15275252320.20.35118845841.5275252317

    Br52/2

    systemHIV+mockmediumAd-IkB/HIV+Ad-IkB/mockAd-IkB/mediumAd/HIV+Ad/mockAd-medium

    average4724224.96.24.2538.37.16.9

    14822214.76.63.94367.26.5

    2491918.54.96.14.4376.86.3

    34624214.66.54.2396.56.1

    average47.522.2520.6254.73333333336.44.1837.33333333336.83333333336.3

    SD1.52752523172.51661147841.4433756730.15275252320.26457513110.23065125191.52752523170.35118845840.2

    dane i wykr promoter C3

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    Elisa NFkB controls z knockout

    systemcontrol+Competition cIL-1 betaIL-6HIV+mockmedium

    average0.2170.0330.2040.1240.1560.0620.047

    10.2170.2170.1240.160.060.047

    20.2140.0360.2080.1210.150.0610.044

    30.220.0330.2040.1250.1620.0640.049

    average0.2170.03450.20966666670.12333333330.15733333330.06166666670.0466666667

    SD0.0030.00212132030.00665832810.0020816660.00642910050.0020816660.0025166115

    HIV [2pg]HIV [4pg]TNF[10U/ml]IL-1[5ng/ml]control extmediumpositive controlcompetition control

    av0.20.30.350.530.0270.0240.545-0.01

    0.30.40.40.530.0260.0230.54-0.01

    0.280.350.390.520.0250.0240.542-0.011

    av0.260.350.380.52666666670.0260.02366666670.5423333333-0.0103333333

    SD0.05291502620.050.02645751310.00577350270.0010.00057735030.00251661150.0005773503

    Ttest0.00156259920.00035917490.00002060.00000000.00000000.0000007

    HIV [1pg]HIV [2.5pg]TNF-alfaIL-1 betamockmediumpositive controlcompetition control

    av0.280.370.40.530.0260.0240.545-0.01

    0.30.40.40.530.0260.0230.54-0.01

    0.280.350.390.520.0250.0240.542-0.011

    av0.28666666670.37333333330.39666666670.52666666670.02566666670.02366666670.5423333333-0.0103333333

    SD0.01154700540.02516611480.00577350270.00577350270.00057735030.00057735030.00251661150.0005773503

    Ttest0.00000255570.00001811070.00000000.00000000.00000000.0000002

    wykres Elisa NFkB contr z Knock

    cell signalling involved in the activation of C3 gene expression

    HIVmockmediumCape/HIVCape/mockCape/mediumGenistein/HIVGenistein/mockGenistein/mediumAG17/HIVAG17/mockAG17/medium

    24h1410.672.90.580.4931.170.96.30.630.69

    13.70.90.592.40.550.512.61.280.85.80.90.77

    15.21.10.712.20.610.522.91.41.15.70.860.82

    av14.310.65666666672.50.580.50666666672.83333333331.28333333330.93333333335.93333333330.79666666670.76

    SD0.79372539330.10.06110100930.36055512750.030.01527525230.20816659990.11503622620.15275252320.32145502540.145716620.0655743852

    test

    3d15.540.6560.783.50.40.93.12.11.86.70.780.5

    16.40.70.793.40.520.913.22.21.66.40.980.6

    16.30.630.822.950.490.893.52.31.56.20.890.67

    av16.080.6620.79666666673.28333333330.470.93.26666666672.21.63333333336.43333333330.88333333330.59

    SD0.47031904070.0353836120.020816660.29297326390.062449980.010.20816659990.10.15275252320.25166114780.1001665280.0854400375

    SD

    HIVmockmediumCape/HIVCape/mockCape/mediumGenistein/HIVGenistein/mockGenistein/mediumAG17/HIVAG17/mockAG17/medium

    24h14.310.65666666672.50.580.50666666672.83333333331.28333333330.93333333335.93333333330.79666666670.76

    3d16.080.6620.79666666673.28333333330.470.93.26666666672.21.63333333336.43333333330.88333333330.59

    SD240.79372539330.10.06110100930.36055512750.030.01527525230.20816659990.11503622620.15275252320.32145502540.145716620.0655743852

    SD3d0.47031904070.0353836120.020816660.29297326390.062449980.010.20816659990.10.15275252320.25166114780.1001665280.0854400375

    wykres Elisa NFkB contr z Knock

    14.316.08350.79372539330.47031904071

    10.6620.93333333330.10.0353836120.1527525232

    0.65666666670.79666666670.96333333330.06110100930.020816660.118462371

    2.53.28333333333.33333333330.36055512750.29297326390.4509249753

    0.580.470.75666666670.030.062449980.0585946528

    0.50666666670.90.80.01527525230.010.1

    2.83333333333.26666666674.10.20816659990.20816659990.1732050808

    1.28333333332.22.46666666670.11503622620.10.2516611478

    0.93333333331.63333333332.09333333330.15275252320.15275252320.1101514109

    5.93333333336.433333333311.40.32145502540.25166114781.1532562595

    0.79666666670.88333333330.91333333330.145716620.1001665282.74

    0.760.590.13233333330.06557438520.08544003750.0924463809

    24h

    3d

    7d

    cell extract

    Relative quantification; Fold change

    Cell signalling involved in the activation of C3 gene expression

    OD dane NFkB

    000.79372539330.4703190407

    000.10.035383612

    000.06110100930.02081666

    000.36055512750.2929732639

    000.030.06244998

    000.01527525230.01

    000.20816659990.2081665999

    000.11503622620.1

    000.15275252320.1527525232

    000.32145502540.2516611478

    000.145716620.100166528

    000.06557438520.0854400375

    24h

    3d

    cell extract

    Fold change [C3 mRNA]

    neutralization of Il6

    neutralization of Il6

    135.33333333336.1101009266

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Re;ative Luciferase Activity [RLU]

    Inhib December grap1 July 20,07

    135.33333333336.1101009266

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Re;ative Luciferase Activity [RLU]

    GrapInhDec July 20,07

    HIVmockmediumCape/HIVCape/mockCape/mediumP38/HIVP38/mockP38/mediumSB580/HIVSB580/mockSB580/mediumSB190/HIVSB190/mockSB580/mediumAG17/HIVAG17/mockAG17/mediumJNK/HIVJNK/mockJNK/mediumGenistein/HIVGenistein/mockGenistein/medium

    135.33333333336566.33333333335.56666666675.55.5333333333100.333333333311185.333333333333.333333333337.666666666733.33333333332121.666666666721.666666666753.666666666751.66666666674965.666666666747.3333333333493.66666666675.33333333333.6666666667Average

    6.11010092664.35889894351.52752523170.51316014390.50.923760430717.6162803498.18535277198.96288643984.93288286238.504900548110.40832999734.35889894358.96288643988.08290376875.50757054736.65832811855.291502622111.01514109462.51661147842.64575131110.57735026920.57735026920.5773502692SD

    0.00008431090.00001958870.00001947480.00002075310.02798383280.00100840240.024151360.00113383070.00774020590.00827556490.00024601170.00122031550.04907193280.01557401090.00690512192.51661147840.0055620.00001740970.00001942550.0000174097Ttest

    GrapInhDec July 20,07

    135.33333333336.1101009266

    37916.8226038413

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    Inhibitors December or1 graph

    1NFkB ELISA

    PROTEINAVERAGESD

    IL-1141.66666677.637626158

    TNF-alfa108.66666673.214550254

    HIV [0.5]10.333333331.040833

    HIV [1pg]19.166666672.020725942

    HIV [2.5pg]20.766666671.078579312

    mock0.30.2

    medium0.2433333330.049328829

    IL-1512.66666676.429100507

    TNF-alfa457.76666678.494900431

    HIV [0.5]87.333333333.214550254

    HIV [1pg]191.66333336.345079458

    HIV [2.5pg]236.666666712.58305739

    mock3.510.5

    medium30.1

    IL-1 betaTNF-alfaHIV [0.5pg]HIV [1pg]HIV [2.5pg]mockmedium

    av3d141.66108.6610.3319.1620.760.30.25

    av7d512.66457.7687.33191.66236.661412.5

    SD7.63.21.0421.0732

    Sd6.48.43.26.312.532.5

    IL-1HIV [0.5pg]HIV [1pg]HIV [2.5 pg]mock cmediumIL-1HIV [0.5]HIV [1pg]HIV [2.5 pg]mock cmedium

    average10.33333333333.24.85.33333333331.066666666718.76666666673.53333333334.26666666673.73333333331.23333333331.1666666667

    SD0.57735026920.11.31148770490.28867513460.20816659990.36055512750.49328828620.35118845840.30550504630.46188021540.11547005380.1154700538

    Ttest0.0000127030.00008921650.00822227110.00003178290.00001350040.0004205250.00008733320.0008104185

    IL-1 betaHIV [0.5pg]HIV [1pg]HIV [2.5pg]mockmedium

    av24h13.333.24.85.5511.1

    av7d93.64.36.51.21.6

    SD0.570.11.30.20.20.4

    SD0.50.350.30.40.20.1

    HIV [0.5pg]HIV [1pg]HIV [2.5pg]mockmedium

    24h3.24.85.5511.1

    7d3.64.36.51.21.6

    SD0.11.30.20.20.4

    SD0.350.30.40.20.1

    10.33333333330.5773502692

    3.20.1

    4.81.3114877049

    5.33333333330.2886751346

    1.06666666670.2081665999

    10.3605551275

    8.76666666670.4932882862

    3.53333333330.3511884584

    4.26666666670.3055050463

    3.73333333330.4618802154

    1.23333333330.1154700538

    1.16666666670.1154700538

    48h

    cell extract

    Fold change [Q-PCR]

    000.570.5

    000.10.35

    001.30.3

    000.20.4

    000.20.2

    000.40.1

    24h

    7d

    cell extract

    C3 mRNA (FC)

    000.10.35

    001.30.3

    000.20.4

    000.20.2

    000.40.1

    24h

    7d

    mRNA (Fold Change)

    13.3390.570.5

    3.23.60.10.35

    4.84.31.30.3

    5.556.50.20.4

    11.20.20.2

    1.11.60.40.1

    24h

    7d

    cell extract

    Fold hange [mRNA]

    13.3390.570.5

    3.23.60.10.35

    4.84.31.30.3

    5.556.50.20.4

    11.20.20.2

    1.11.60.40.1

    24h

    7d

    cell extract

    Fold hange [mRNA]

    9.750.75

    6.30.7

    1.5333333330.251661148

    1.8750.275

    3.190.69

    0.8750.075

    1.010.01

    48h

    cell extract

    Fold change [RLU]

    9.750.75

    6.30.7

    1.5333333330.251661148

    1.8750.275

    3.190.69

    0.8750.075

    1.010.01

    48h

    cell extract

    Fold change [RLU]

    9.750.75

    6.30.7

    1.5333333330.251661148

    1.8750.275

    3.190.69

    0.8750.075

    1.010.01

    48h

    cell extract

    Fold change [RLU]

    9.750.75

    6.30.7

    1.5333333330.251661148

    1.8750.275

    3.190.69

    0.8750.075

    1.010.01

    48h

    cell extract

    Fold change [RLU]

    IL-1betaTNF-alfaHIV [0.5pg]HIV [1pg]HIV [2.5pg]mockmedium

    9.756.31.5333333331.8753.190.8751.01

    SD0.750.70.2516611480.2750.690.0750.01

    00.251661148

    00.275

    00.69

    00.075

    00.01

    48h

    Relative Luciferase Activity [RLU] Fold Change

    0.2170.003

    0.0330.0021213203

    0.2040.0066583281

    0.1560.0064291005

    0.0620.002081666

    0.0470.0025166115

    0.0560.0026457513

    0.060.001

    0.040.01

    nuclear extract

    OD value [450nm]

    0.2170.003

    0.0330.0021213203

    0.2040.0066583281

    0.1560.0064291005

    0.0620.002081666

    0.0470.0025166115

    0.0560.0026457513

    0.060.001

    0.040.01

    nuclear extract

    OD value [450nm]

    0.2170.003

    0.0330.0021213203

    0.2040.0066583281

    0.1560.0064291005

    0.0620.002081666

    0.0470.0025166115

    0.0560.0026457513

    0.060.001

    0.040.01

    nuclear extract

    OD value [450nm]

    controls

    osobno IL-1, IL-6

    systemcontrol+Competition cIL-1 betaHIV+mockmediumCape/HIV+Cape/mockCape/medium

    average0.2170.0330.2040.1560.0620.0470.0560.060.04

    10.2170.2170.160.060.0470.0540.060.03

    20.2140.0360.2080.150.0610.0440.0550.0590.05

    30.220.0330.2040.1620.0640.0490.0590.0610.04

    average0.2170.03450.20966666670.15733333330.06166666670.04666666670.0560.060.04

    SD0.0030.00212132030.00665832810.00642910050.0020816660.00251661150.00264575130.0010.01

    wirusy

    systemcontrol+Competition cmockmediumHIV+Ad-v/HIV+Ad-v/mockAd-vAd-IkB/HIV+Ad-IkB/mockAd-IkBCape/HIVCape/mock

    average0.2170.0330.0620.0470.1560.1320.1130.1010.0510.0530.0490.0560.06

    10.2170.060.0470.160.1340.1150.1080.0560.0530.050.0540.06

    20.2140.0360.0610.0440.150.1380.1180.0990.0530.0560.0470.0550.059

    30.220.0330.0640.0490.1620.1240.1060.0960.0440.050.050.0590.061

    average0.2170.03450.06166666670.04666666670.15733333330.1320.1130.1010.0510.0530.0490.0560.06

    SD0.0030.00212132030.0020816660.00251661150.00642910050.00721110260.0062449980.0062449980.0062449980.0030.00173205080.00264575130.001

    0.2170.003

    0.0330.0149899967

    0.2040.0066583281

    0.1240.002081666

    0.1560.0357258077

    0.1320.0072111026

    0.1130.006244998

    0.1010.006244998

    0.0510.006244998

    0.0530.003

    0.0490.0017320508

    0.0560.0026457513

    0.060.001

    0.0620.002081666

    0.0470.0025166115

    cell extract

    OD value [450nm]

    IL-6HIVmockmediummouse IgGMoAb anti-IL6mouse IgG+HIVMoAb anti-IL6+HIV

    Fch1.81.510.91.41.041.71

    SD

    4.52.82.71.83.92.3

    42.72.82.23.62.1

    3.73.22.662.23.31.8

    SD0.40.20.20.150.30.260.40.28

    Fold Ch1.81.510.91.41.041.71

    1.80.4

    1.50.2

    10.2

    0.90.15

    1.40.3

    1.040.26

    1.70.4

    10.28

    48h

    cell extract

    Fold change [RLU]

    1.80.4

    1.50.2

    10.2

    0.90.15

    1.40.3

    1.040.26

    1.70.4

    10.28

    48h

    cell extract

    Fold change [RLU]

    1570.9539392014

    62.57.7785538502

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.7

    11.50.5

    110.8857388629

    11.42.1166010489

    430.7110365087

    300.4150803135

    385.3605596723

    210.8669486721

    37.64.8967233943

    304.4303047299

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    1570.9539392014

    62.57.7785538502

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.7

    11.50.5

    110.8857388629

    11.42.1166010489

    430.7110365087

    300.4150803135

    385.3605596723

    210.8669486721

    37.64.8967233943

    304.4303047299

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    IL-1TNF-HIVmediummockCape/HIVCape/mediumPDTC/HIVPDTC/mediumAG18/HIVAG18/mediumU126/HIVU126/mediumWortmanin/HIVWortmanin/mediumSQ-22536/HIVSQ-22536/mediumCalphostin/HIVCalphostin/medium

    15762.5average31111533.61311.51111.43733382137.6302825

    156.55525.513163.1234.01213.091212.1936323320.4632.7834.462724

    158.170.5340.0111182.7253.38413.0911.510.712.2353343.662242.5725.62223

    156.461.9726.959113.1523.40412.811110.461336.732.637.3420.5437.4529.943528

    15762.5average30.82111533.612.996666666711.511.086666666711.44330382137.6302825

    0.95393920147.7785538502SD7.991726972323.60555127550.23859798830.35694257240.16165807540.50.88573886292.11660104890.71103650870.41508031355.36055967230.86694867214.89672339434.43030472996.55743852432.6457513111

    0.00000320.0006591335Ttest0.03534436910.00452958730.00550742530.01506078120.02077571580.01074868790.21012594370.09889791720.83434125080.0035112510.04869066430.0029959170.01043022450.03959261940.0179479132

    tosamo z Il1

    IL-1 betaTNF- alfaHIVmediummockCape/HIVCape/mediumPDTC/HIVPDTC/mediumAG18/HIVAG18/mediumU126/HIVU126/mediumWortmanin/HIVWortmanin/mediumSQ-22536/HIVSQ-22536/mediumCalphostin/HIVCalphostin/medium

    15762.531111533.61311.51111.44330382137.6302825

    156.55525.513163.1234.01213.091212.1936323320.4632.7834.462724

    158.170.5340.0111182.7253.38413.0911.510.712.2353343.662242.5725.62223

    156.461.9726.959113.1523.40412.811110.461336.732.637.3420.5437.4529.943528

    15762.530.82111533.612.996666666711.511.086666666711.44330382137.6302825

    SD0.95393920147.77855385027.991726972323.60555127550.23859798830.35694257240.70.50.88573886292.11660104890.71103650870.41508031355.36055967230.86694867214.89672339434.43030472996.55743852432.6457513111

    0.00000320.00065913350.03534436910.00452958730.00550742530.01506078120.02077571580.01074868790.21012594370.09889791720.83434125080.0035112510.04869066430.0029959170.01043022450.03959261940.0179479132

    HIV [1pg]HIV [2.5pg]TNF-alfaIL-1 betamockmediumpositive controlcompetition control

    0.20.30.350.530.0270.0240.545-0.01

    0.220.320.360.550.0230.0220.546-0.011

    0.210.330.3670.60.0210.0230.546-0.012

    av

    SD

    MBD0002EB81.xls

    C3protein wykres or

    141.66512.667.66.4

    108.66457.73.28.4

    10.3387.331.043.2

    19.16191.6626.3

    20.762371.0712.5

    0.311.533

    0.2410.5

    C

    3d

    7d

    supernatants

    C3 Protein [ng/ml]

    inhibitors 2b graph

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    graph cont inhib 2b

    1577.9917269723

    62.52

    113.6055512755

    150.2385979883

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    kontrole do inhib 2b

    HIVmedmock cIL-1TNF-mediummock c

    average31111515762.51115

    25.51316156.5551316

    40.011118158.170.531118

    26.95911156.461.97911

    average30.82111515762.51115

    SD7.991726972323.60555127550.95393920147.778553850223.6055512755

    Ttest0.03534436910.00000031680.0006591335

    IL-1 betaTNF-alfamediummock

    15762.51115

    156.5551316

    158.170.531118

    156.461.97911

    av15762.51115

    SD0.95393920147.778553850223.6055512755

    0.0006591335

    inhibitors2b

    HIVIL-1 betaTNF- alfamediummockCape/HIVCape/mediumPDTC/HIVPDTC/mediumAG18/HIVAG18/mediumU126/HIVU126/mediumWortmanin/HIVWortmanin/mediumSQ-22536/HIVSQ-22536/mediumCalphostin/HIVCalphostin/medium

    3115762.5111533.61311.51111.43733382137.6302825

    7.99172697230.95393920147.778553850223.60555127550.23859798830.35694257240.16165807540.50.88573886292.11660104890.71103650870.41508031355.36055967230.86694867214.89672339434.43030472996.55743852432.6457513111

    19-Jul

    HIVmediummockCape/HIVCape/mediumPDTC/HIVPDTC/mediumAG18/HIVAG18/mediumU126/HIVU126/mediumCalphostin/HIVCalphostin/medium

    av31111533.61311.51111.437332825

    SD7.991726972323.60555127550.23859798830.35694257240.16165807540.50.88573886292.11660104890.71103650870.41508031356.55743852432.6457513111

    controle do graph inhib2b wl

    controle do graph inhib2b wl

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wl graph 1 Elisa p50NFkB

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    graphknock 5000vpC3 prom

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wl graph ad 5000 C3 prom bz Il1

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    daneknockout 5000vp promotor C3

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    1 EL p50NFkB

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    EL p50 controls

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    mC3RNA 24h, 3d signal transd

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    inhib2A wlasc grapg bez Il1

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    graph Inhib 2A bez Il1

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    C3 protein wykres

    C3 protein wykres

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    inhibitors 2A

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    C3 proteimna graph or

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    C3 proteina

    C3 proteina

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    1NFkB ELISA

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    Exp 02/05Ad 5000vp/cellAd-IkB/mockAd-IkB/HIV

    Br52/2Adenovirus-IkB

    systemHIV+mockmediumAdenovirus-IkBAd-IkB/mockAd-IkB/HIVAdenovirusAd/mockAd/HIV+

    average4724224.256.24.96.97.138.3

    14822213.946.64.76.57.236

    2491918.54.46.14.96.36.837

    34624214.26.54.66.16.539

    average47.522.2520.6254.186.44.73333333336.36.833333333337.3333333333

    SD1.52752523172.51661147841.4433756730.23065125190.26457513110.15275252320.20.35118845841.5275252317

    Br52/2

    systemHIV+mockmediumAd-IkB/HIV+Ad-IkB/mockAd-IkB/mediumAd/HIV+Ad/mockAd-medium

    average4724224.96.24.2538.37.16.9

    14822214.76.63.94367.26.5

    2491918.54.96.14.4376.86.3

    34624214.66.54.2396.56.1

    average47.522.2520.6254.73333333336.44.1837.33333333336.83333333336.3

    SD1.52752523172.51661147841.4433756730.15275252320.26457513110.23065125191.52752523170.35118845840.2

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    systemcontrol+Competition cIL-1 betaIL-6HIV+mockmedium

    average0.2170.0330.2040.1240.1560.0620.047

    10.2170.2170.1240.160.060.047

    20.2140.0360.2080.1210.150.0610.044

    30.220.0330.2040.1250.1620.0640.049

    average0.2170.03450.20966666670.12333333330.15733333330.06166666670.0466666667

    SD0.0030.00212132030.00665832810.0020816660.00642910050.0020816660.0025166115

    HIV [2pg]HIV [4pg]TNF[10U/ml]IL-1[5ng/ml]control extmediumpositive controlcompetition control

    av0.20.30.350.530.0270.0240.545-0.01

    0.30.40.40.530.0260.0230.54-0.01

    0.280.350.390.520.0250.0240.542-0.011

    av0.260.350.380.52666666670.0260.02366666670.5423333333-0.0103333333

    SD0.05291502620.050.02645751310.00577350270.0010.00057735030.00251661150.0005773503

    Ttest0.00156259920.00035917490.00002060.00000000.00000000.0000007

    HIV [1pg]HIV [2.5pg]TNF-alfaIL-1 betamockmediumpositive controlcompetition control

    av0.280.370.40.530.0260.0240.545-0.01

    0.30.40.40.530.0260.0230.54-0.01

    0.280.350.390.520.0250.0240.542-0.011

    av0.28666666670.37333333330.39666666670.52666666670.02566666670.02366666670.5423333333-0.0103333333

    SD0.01154700540.02516611480.00577350270.00577350270.00057735030.00057735030.00251661150.0005773503

    Ttest0.00000255570.00001811070.00000000.00000000.00000000.0000002

    cell signalling involved in the activation of C3 gene expression

    HIVmockmediumCape/HIVCape/mockCape/mediumGenistein/HIVGenistein/mockGenistein/mediumAG17/HIVAG17/mockAG17/medium

    24h1410.672.90.580.4931.170.96.30.630.69

    13.70.90.592.40.550.512.61.280.85.80.90.77

    15.21.10.712.20.610.522.91.41.15.70.860.82

    av14.310.65666666672.50.580.50666666672.83333333331.28333333330.93333333335.93333333330.79666666670.76

    SD0.79372539330.10.06110100930.36055512750.030.01527525230.20816659990.11503622620.15275252320.32145502540.145716620.0655743852

    test

    3d15.540.6560.783.50.40.93.12.11.86.70.780.5

    16.40.70.793.40.520.913.22.21.66.40.980.6

    16.30.630.822.950.490.893.52.31.56.20.890.67

    av16.080.6620.79666666673.28333333330.470.93.26666666672.21.63333333336.43333333330.88333333330.59

    SD0.47031904070.0353836120.020816660.29297326390.062449980.010.20816659990.10.15275252320.25166114780.1001665280.0854400375

    SD

    HIVmockmediumCape/HIVCape/mockCape/mediumGenistein/HIVGenistein/mockGenistein/mediumAG17/HIVAG17/mockAG17/medium

    24h14.310.65666666672.50.580.50666666672.83333333331.28333333330.93333333335.93333333330.79666666670.76

    3d16.080.6620.79666666673.28333333330.470.93.26666666672.21.63333333336.43333333330.88333333330.59

    SD240.79372539330.10.06110100930.36055512750.030.01527525230.20816659990.11503622620.15275252320.32145502540.145716620.0655743852

    SD3d0.47031904070.0353836120.020816660.29297326390.062449980.010.20816659990.10.15275252320.25166114780.1001665280.0854400375

    14.316.08350.79372539330.47031904071

    10.6620.93333333330.10.0353836120.1527525232

    0.65666666670.79666666670.96333333330.06110100930.020816660.118462371

    2.53.28333333333.33333333330.36055512750.29297326390.4509249753

    0.580.470.75666666670.030.062449980.0585946528

    0.50666666670.90.80.01527525230.010.1

    2.83333333333.26666666674.10.20816659990.20816659990.1732050808

    1.28333333332.22.46666666670.11503622620.10.2516611478

    0.93333333331.63333333332.09333333330.15275252320.15275252320.1101514109

    5.93333333336.433333333311.40.32145502540.25166114781.1532562595

    0.79666666670.88333333330.91333333330.145716620.1001665282.74

    0.760.590.13233333330.06557438520.08544003750.0924463809

    24h

    3d

    7d

    cell extract

    Relative quantification; Fold change

    Cell signalling involved in the activation of C3 gene expression

    0.79372539330.4703190407

    0.10.035383612

    0.06110100930.02081666

    0.36055512750.2929732639

    0.030.06244998

    0.01527525230.01

    0.20816659990.2081665999

    0.11503622620.1

    0.15275252320.1527525232

    0.32145502540.2516611478

    0.145716620.100166528

    0.06557438520.0854400375

    24h

    3d

    cell extract

    Fold change [C3 mRNA]

    135.33333333336.1101009266

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Re;ative Luciferase Activity [RLU]

    135.33333333336.1101009266

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Re;ative Luciferase Activity [RLU]

    141.66512.66

    108.66457.7

    10.3387.33

    19.16191.66

    20.76237

    0.311.5

    0.2410.5

    3d

    7d

    supernatants

    C3 Protein [ng/ml]

    141.66512.66

    108.66457.7

    10.3387.33

    19.16191.66

    20.76237

    0.311.5

    0.2410.5

    3d

    7d

    supernatants

    C3 Protein [ng/ml]

    HIVmockmediumCape/HIVCape/mockCape/mediumP38/HIVP38/mockP38/mediumSB580/HIVSB580/mockSB580/mediumSB190/HIVSB190/mockSB580/mediumAG17/HIVAG17/mockAG17/mediumJNK/HIVJNK/mockJNK/mediumGenistein/HIVGenistein/mockGenistein/medium

    135.33333333336566.33333333335.56666666675.55.5333333333100.333333333311185.333333333333.333333333337.666666666733.33333333332121.666666666721.666666666753.666666666751.66666666674965.666666666747.3333333333493.66666666675.33333333333.6666666667Average

    6.11010092664.35889894351.52752523170.51316014390.50.923760430717.6162803498.18535277198.96288643984.93288286238.504900548110.40832999734.35889894358.96288643988.08290376875.50757054736.65832811855.291502622111.01514109462.51661147842.64575131110.57735026920.57735026920.5773502692SD

    0.00008431090.00001958870.00001947480.00002075310.02798383280.00100840240.024151360.00113383070.00774020590.00827556490.00024601170.00122031550.04907193280.01557401090.00690512192.51661147840.0055620.00001740970.00001942550.0000174097Ttest

    135.33333333336.1101009266

    37916.8226038413

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    141.66512.66

    108.66457.7

    10.3387.33

    19.16191.66

    20.76237

    0.311.5

    0.2410.5

    3d

    7d

    supernatants

    C3 Protein [ng/ml]

    PROTEINAVERAGESD

    IL-1141.66666677.637626158

    TNF-alfa108.66666673.214550254

    HIV [0.5]10.333333331.040833

    HIV [1pg]19.166666672.020725942

    HIV [2.5pg]20.766666671.078579312

    mock0.30.2

    medium0.2433333330.049328829

    IL-1512.66666676.429100507

    TNF-alfa457.76666678.494900431

    HIV [0.5]87.333333333.214550254

    HIV [1pg]191.66333336.345079458

    HIV [2.5pg]236.666666712.58305739

    mock3.510.5

    medium30.1

    IL-1 betaTNF-alfaHIV [0.5pg]HIV [1pg]HIV [2.5pg]mockmedium

    AV3d141.66108.6610.3319.1620.760.30.24

    Av7d512.66457.787.33191.6623711.510.5

    SD3d7.633.21.042.021.070.20.04

    SD7d6.428.43.26.312.53.52

    HIV [1pg]HIV [2.5pg]TNF-alfaIL-1 betamockmediumpositive controlcompetition control

    0.20.30.350.530.0270.0240.545-0.01

    0.220.320.360.550.0230.0220.546-0.011

    0.210.330.3670.60.0210.0230.546-0.012

    av

    SD

    MBD0009EEC5.xls

    22,3

    53

    24

    50

    5.65

    2.5

    1.4

    0.5

    25

    22

    22.5

    1-control(+)HIV, 2-Control(-)HIV, 3-Calphostin-C, 4-SQ22536, 5-CAPE 1:10000, 6-CAPE 1:15000, 7-Genistein 1:1000, 8-Genistein 1:2000, 9-PMA, 10-Pertusis toxin, 11-8Br-cAMP

    inhibitors

    RATIO pGLC3pro/pRLTK dual luciferase assay

    Br22/3 C3 PROMOTER INDUCTION by HIV with INHIBITORS

    22,3+-

    5312

    2421

    5033

    5.654.5

    2.54.6

    1.40.98

    0.50.4

    2522

    2215

    22.515

    contr(+)/(-)

    Calph

    SQ22536

    CAPE:10000

    CAPE;15000

    Genist:1000

    Genist:2000

    PMA

    Pertusis toxin

    8Br-cAMP

    +HIV

    -HIV

    inhibitors with/w-o HIV

    RATIO pGLC3pro/pRLTK Dual Luciferase Assay

    BRAIN 22/3

    Sheet1

    5312

    2421

    5033

    5.654.5

    2.54.6

    1.40.98

    0.50.4

    2522

    2215

    22.515

    Sheet1

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    inhibitors(-)HIV

    inhibitors

    Ratio pGlC3/pRLTH

    C3 induction promoter - inhibitors without HIV

    Br22,4

    Br22,4

    49

    25

    16.5

    44

    18

    7.6

    4.7

    1.2

    20

    22

    31.4

    35

    Br22/4 inhibitors (+) HIV

    inhibitors

    Ratio pGL3C/pRLTK

    -

    20

    22.5

    30

    33.5

    11

    9.7

    1.3

    3.4

    20

    20

    32

    25

    inhibitors(+) HIV

    inhibitors

    Ratio pGLC3/pRLTK Dual-Luciferase Assay

    BR 22/4 C3 induction promoter

    49

    25

    16.5

    44

    18

    7.6

    4.7

    1.2

    20

    22

    31.4

    35

    inhibitors (-) HIV

    18,4

    50

    46

    26

    42

    18.4

    126

    84

    72.5

    75.6

    inhibitors (+) HIV

    inhibitors

    Ratio pGLC3/pRLTK

    Br 18/5 C3 induction promoter

    18,4 bez HIV

    23

    42

    35

    56

    16

    72

    45

    80

    38

    inhibitors (-) HIV

    br4p4

    4920

    2522.5

    16.530

    4433.5

    1811

    7.69.7

    4.71.3

    1.23.4

    2020

    2220

    31.432

    3525

    control(+)/(-)

    Calph:1000

    Calph10-5

    SQ22536

    CAPE:20000

    CAPE:15000

    Genist:2000

    Genist:1000

    8-Br-cAMP(1pgHIV)

    PMA(1pgHIV)

    Pertusis t1x

    Pertusis t5x

    (+)HIV

    (-)HIV

    inhibitors with/w-o HIV

    RATIO pGLC3pro/pRLTK

    Brain 22/4

    C 3 promoter induction March06

    7.5

    4.5

    2.5

    3.8

    1

    cell extract

    Fold change [Relative Luciferase Unit

    C3 promoter induction by HIV in HFA

    MVP and C3promoter

    7.5

    4.5

    2.5

    3.8

    1

    cell extract

    Fold change [Luciferase Activity Unit]

    C3 promoter induction by HIV[MVP] in HFA

    Sheet14

    IL1-beta[10ng/ml]TNF[10U/ml]MVP[2pgP24/cell]MVP 5pgP24/cellcontrol ext.

    7.54.52.53.81

    18,4por

    5023

    4642

    2635

    4256

    18.416

    12672

    8445

    72.580

    75.638

    control(+)/(-)

    Calph

    CAPE :20000

    CAPE :50000

    Genist:2000

    8-Br-c-AMP(0.5 pg ADA)

    PMA

    SQ22536

    Pertusis toxin

    (+)HIV

    (-)HIV

    inhibitors with/w-o HIV

    RATIO pGLC3pro/pRLTK

    BRAIN 18/5

    oct11

    4421

    3515

    7737

    1812

    6045.6

    3833

    3016.6

    1816

    4641

    1.61

    2.51.6

    2515

    +HIV/HIV-

    +HIV

    Daid.

    Wort.

    PDTC

    U126

    SB202190

    SB203580

    SP

    PT

    CAPE

    Gen

    Calp

    inhibitors with/w-oHIV

    Ratio pGLC3pro/RLTK

    Brain22/4 inhib part1and2 October11

    br22part2inh

    4421

    3515

    7737

    1812

    6045.6

    3833

    3016.6

    1816

    4641

    1.61

    2.51.6

    2515

    Sheet2

    492050237012

    2522.546427030

    16.5302635112171

    4433.542562.42

    181118.41645

    7.69.7126728488

    4.71.3844514090

    1.23.472.580113150

    202075.638147130

    22202643

    31.4325158

    35254072

    82107

    107262

    159130

    45104

    6451

    Sheet2

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    +HIV

    -HIV

    inhibitors with/or without HIV

    RATIO pGLC3/RLTK

    BRAIN 22/3 # NOV12

    Il1 beta Jims

    160

    126

    125

    Jims stock U/ml

    Influence of IL1-beta on induction C3 promoter

    C 3 gene expr 48h

    8.68

    12.3

    1

    0.6

    48h

    cell extract

    Fold change

    C3 gene expression in HFA by HIV

    Mouse signal transduction study

    217

    130

    140

    38

    60

    47

    227

    206

    100

    11

    14

    11

    17

    15

    20

    59

    80

    78

    340

    cell extract

    Fold change

    Effect of signal transduction's inhibitors on C3 induction promoter by HIV in primary mouse astrocytes

    C3 promoter and mouse 2

    238

    152

    138

    1.5

    1.3

    46

    35

    20

    44

    17.5

    23

    25

    80

    122

    104

    173

    193

    227

    340

    cell extract

    Fold change

    Effect of signal transduction's inhibitors on C3 promoter induction by HIV in primary mouse astrocytes

    Sheet11

    NDKcontrol extmediumSB 190/NDKSB190/control extSB190/mediumCalphostion/NDKCalphostin/control ext.Calphostin/mediumJNK inh/NDKJNKinh/cont.extJNK/mediumPDTC/NDKPDTC/control ext.PDTC/mediumSB580/NDKSB580/control extSB580/mediumIL/TNF

    217130140386047227206100111411171520598078340

    NDKcontrol extmediumCape/NDKCape/control extCape/mediumGenistein/NDKGenistein/control extGenistein/mediumPD 98/NDKPD98/control extPD 98/mediumAG18/NDKAG18/control extAG18/mediump38/NDKp38/control extp38/mediumIL/TNF

    2381521381.51.34635204417.5232580122104173193227340

    mouse and inhibitors

    217.5

    130

    140

    SB190

    38

    60

    47

    SB580

    59

    80

    78

    Calphostin

    227

    206

    100

    JNK

    11

    14

    11

    PDTC

    17

    15

    20

    SQ

    130

    170

    144

    Pertusis toxin

    236

    225

    205

    PD 98

    17.5

    23

    25

    AG18

    80

    122

    104

    P38

    173

    193

    227

    MFA

    cell extract

    Relative Luciferase Activity [RLA]

    Effect of signal transduction inhibitors on C3 promoter induction by HIV in primary mouse astrocytes

    Sheet10

    NDK217.5

    c.ext130

    medium140

    SB190

    + NDK38

    c.ext60

    medium47

    SB580

    + NDK59

    c.ext80

    medium78

    Calphostin

    + NDK227

    c.ext206

    medium100

    JNK

    + NDK11

    c.ext14

    medium11

    PDTC

    + NDK17

    c.ext15

    medium20

    SQ

    + NDK130

    c.ext170

    medium144

    Pertusis toxin

    + NDK236

    c.ext225

    medium205

    PD 98

    + NDK17.5

    c.ext23

    medium25

    AG18

    + NDK80

    c.ext122

    medium104

    P38

    + NDK173

    c.ext193

    medium227

    gene expr 7 days

    37.6

    3378.5

    1

    0.84

    7 days

    cell extract

    Fold change

    C 3 gene expression in HFA by HIV

    Sheet9

    MVP[5pgP24/cellIL1-beta[10ng/ml]control extractmedium

    37.63378.510.84

    MVP[5pgP24/cell]IL1-beta[10ng/ml]control extractmedium

    8.6812.310.6

    Sheet8

    1.0430.1891.0150.545

    C3 gene exp 7days

    4.84

    37.6

    1

    376.7

    3378.6

    7 days

    cell extract

    fold change

    C3 gene expression by HIV {MVP} in HFA on 7 days of infection

    Sheet7

    7days

    MVP [J]1pg5pgc.extTNFIL1

    4.8437.61376.73378.6

    Sheet4

    12negative16020U/ml13720ng/ml138

    10720012610U/ml11910ng/ml119

    601001250.2U/ml1382ng/ml137

    5650

    Sheet4

    0

    0

    0

    0

    -/+HIV

    Ratio pGLC3pro/RLTK

    Induction of C3 promoter by HIV dose dependent

    C3 gene expr march24

    0

    0

    0

    Jim's stock

    Il 1-beta [U/ml]

    Ratio pGLC3 pro/RLTK

    Influence of IL1-beta on C3 induction promoter

    Sheet13

    0

    0

    0

    New Il1-beta

    IL1-beta [ng/ml]

    Ratio pGLC3pro/RLTK

    Influence of Il1-beta on C3 induction promoter

    p50 NFkB BR37

    1.68

    2.82

    2.44

    3.67

    1

    1.04

    24h

    Cell extract

    Fold change

    C3 gene expresion in HFA by HIV

    p50-p65p

    Panomic dec12

    0

    00.2

    00.3

    00.35

    00.53

    00.027

    00.024

    00.545

    0-0.01

    cell extract

    OD [p50-p65]

    Detection of p50 subunits of heterodimer p50-p65 NFkB in HFA after HIV infection

    Sheet12

    0.2

    0.3

    0.35

    0.53

    0.027

    0.024

    0.545

    -0.01

    OD [NFkBp50]

    Sheet6

    0.20.0529150262

    0.30.05

    0.350.0264575131

    0.530.0057735027

    0.0270.001

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    **

    ***

    ****

    ****

    ****

    cell extract

    OD [NFkB subunit p50]

    Sheet5

    HIV [2pg]HIV [4pg]TNF[10U/ml]IL-1[5ng/ml]control extmediumpositive controlcompetition control

    av0.20.30.350.530.0270.0240.545-0.01

    0.30.40.40.530.0260.0230.54-0.01

    0.280.350.390.520.0250.0240.542-0.011

    av0.260.350.380.52666666670.0260.02366666670.5423333333-0.0103333333

    SD0.05291502620.050.02645751310.00577350270.0010.00057735030.00251661150.0005773503

    Ttest0.00156259920.00035917490.00002060.00000000.00000000.0000007

    NDK

    Sheet3

    NDK fNDK nNL4-3 fIL/TNFc.ext 10ulmedium

    1.682.822.443.6711.04

    3.63.491

    1.60.7614

    5081

    67120

    6040

    116.665

    67.7

    0

    0

    0

    0

    0

    0

    0

    Cape exp

    inhibitor/+-IL1beta/+-HIV

    Ratio pGLC3pro/RLTK

    CAPE/+-HIV/+-IL1beta

    0

    0

    0

    0

    0

    0

    GENISTEIN exp

    inhibitor/+-HIV/+_ IL1-beta

    RATIO pGLC3pro/RLTK

    GENISTEIN/+-HIV/+_IL1-beta

    0

    0

    Controls- HFA brain28/3 infection NL4-3/PBL

    HIV/-HIV

    RATIO pGLC3pro/RLTK

    149

    2430

    148.5184.4

    119.25210.25

    81153

    52.2573.33

    120206.66

    14.6616.33

    2741

    96152.33

    59.33125.33

    71.6670

    00

    2438

    00

    00

    00

    00

    00

    00

    00

    Ratio

    Effect of HIV on the activity of different C3 promoter constructs in HFA

    00

    00

    00

    00

    00

    00

    00

    Ratio

    Effect of HIV on the activity of different C3 promoter constructs in HFA [systemA/2]

    MBD0009EEC5.xls

    22,3

    53

    24

    50

    5.65

    2.5

    1.4

    0.5

    25

    22

    22.5

    1-control(+)HIV, 2-Control(-)HIV, 3-Calphostin-C, 4-SQ22536, 5-CAPE 1:10000, 6-CAPE 1:15000, 7-Genistein 1:1000, 8-Genistein 1:2000, 9-PMA, 10-Pertusis toxin, 11-8Br-cAMP

    inhibitors

    RATIO pGLC3pro/pRLTK dual luciferase assay

    Br22/3 C3 PROMOTER INDUCTION by HIV with INHIBITORS

    22,3+-

    5312

    2421

    5033

    5.654.5

    2.54.6

    1.40.98

    0.50.4

    2522

    2215

    22.515

    contr(+)/(-)

    Calph

    SQ22536

    CAPE:10000

    CAPE;15000

    Genist:1000

    Genist:2000

    PMA

    Pertusis toxin

    8Br-cAMP

    +HIV

    -HIV

    inhibitors with/w-o HIV

    RATIO pGLC3pro/pRLTK Dual Luciferase Assay

    BRAIN 22/3

    Sheet1

    5312

    2421

    5033

    5.654.5

    2.54.6

    1.40.98

    0.50.4

    2522

    2215

    22.515

    Sheet1

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    inhibitors(-)HIV

    inhibitors

    Ratio pGlC3/pRLTH

    C3 induction promoter - inhibitors without HIV

    Br22,4

    Br22,4

    49

    25

    16.5

    44

    18

    7.6

    4.7

    1.2

    20

    22

    31.4

    35

    Br22/4 inhibitors (+) HIV

    inhibitors

    Ratio pGL3C/pRLTK

    -

    20

    22.5

    30

    33.5

    11

    9.7

    1.3

    3.4

    20

    20

    32

    25

    inhibitors(+) HIV

    inhibitors

    Ratio pGLC3/pRLTK Dual-Luciferase Assay

    BR 22/4 C3 induction promoter

    49

    25

    16.5

    44

    18

    7.6

    4.7

    1.2

    20

    22

    31.4

    35

    inhibitors (-) HIV

    18,4

    50

    46

    26

    42

    18.4

    126

    84

    72.5

    75.6

    inhibitors (+) HIV

    inhibitors

    Ratio pGLC3/pRLTK

    Br 18/5 C3 induction promoter

    18,4 bez HIV

    23

    42

    35

    56

    16

    72

    45

    80

    38

    inhibitors (-) HIV

    br4p4

    4920

    2522.5

    16.530

    4433.5

    1811

    7.69.7

    4.71.3

    1.23.4

    2020

    2220

    31.432

    3525

    control(+)/(-)

    Calph:1000

    Calph10-5

    SQ22536

    CAPE:20000

    CAPE:15000

    Genist:2000

    Genist:1000

    8-Br-cAMP(1pgHIV)

    PMA(1pgHIV)

    Pertusis t1x

    Pertusis t5x

    (+)HIV

    (-)HIV

    inhibitors with/w-o HIV

    RATIO pGLC3pro/pRLTK

    Brain 22/4

    C 3 promoter induction March06

    7.5

    4.5

    2.5

    3.8

    1

    cell extract

    Fold change [Relative Luciferase Unit

    C3 promoter induction by HIV in HFA

    MVP and C3promoter

    7.5

    4.5

    2.5

    3.8

    1

    cell extract

    Fold change [Luciferase Activity Unit]

    C3 promoter induction by HIV[MVP] in HFA

    Sheet14

    IL1-beta[10ng/ml]TNF[10U/ml]MVP[2pgP24/cell]MVP 5pgP24/cellcontrol ext.

    7.54.52.53.81

    18,4por

    5023

    4642

    2635

    4256

    18.416

    12672

    8445

    72.580

    75.638

    control(+)/(-)

    Calph

    CAPE :20000

    CAPE :50000

    Genist:2000

    8-Br-c-AMP(0.5 pg ADA)

    PMA

    SQ22536

    Pertusis toxin

    (+)HIV

    (-)HIV

    inhibitors with/w-o HIV

    RATIO pGLC3pro/pRLTK

    BRAIN 18/5

    oct11

    4421

    3515

    7737

    1812

    6045.6

    3833

    3016.6

    1816

    4641

    1.61

    2.51.6

    2515

    +HIV/HIV-

    +HIV

    Daid.

    Wort.

    PDTC

    U126

    SB202190

    SB203580

    SP

    PT

    CAPE

    Gen

    Calp

    inhibitors with/w-oHIV

    Ratio pGLC3pro/RLTK

    Brain22/4 inhib part1and2 October11

    br22part2inh

    4421

    3515

    7737

    1812

    6045.6

    3833

    3016.6

    1816

    4641

    1.61

    2.51.6

    2515

    Sheet2

    492050237012

    2522.546427030

    16.5302635112171

    4433.542562.42

    181118.41645

    7.69.7126728488

    4.71.3844514090

    1.23.472.580113150

    202075.638147130

    22202643

    31.4325158

    35254072

    82107

    107262

    159130

    45104

    6451

    Sheet2

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    00

    +HIV

    -HIV

    inhibitors with/or without HIV

    RATIO pGLC3/RLTK

    BRAIN 22/3 # NOV12

    Il1 beta Jims

    160

    126

    125

    Jims stock U/ml

    Influence of IL1-beta on induction C3 promoter

    C 3 gene expr 48h

    8.68

    12.3

    1

    0.6

    48h

    cell extract

    Fold change

    C3 gene expression in HFA by HIV

    Mouse signal transduction study

    217

    130

    140

    38

    60

    47

    227

    206

    100

    11

    14

    11

    17

    15

    20

    59

    80

    78

    340

    cell extract

    Fold change

    Effect of signal transduction's inhibitors on C3 induction promoter by HIV in primary mouse astrocytes

    C3 promoter and mouse 2

    238

    152

    138

    1.5

    1.3

    46

    35

    20

    44

    17.5

    23

    25

    80

    122

    104

    173

    193

    227

    340

    cell extract

    Fold change

    Effect of signal transduction's inhibitors on C3 promoter induction by HIV in primary mouse astrocytes

    Sheet11

    NDKcontrol extmediumSB 190/NDKSB190/control extSB190/mediumCalphostion/NDKCalphostin/control ext.Calphostin/mediumJNK inh/NDKJNKinh/cont.extJNK/mediumPDTC/NDKPDTC/control ext.PDTC/mediumSB580/NDKSB580/control extSB580/mediumIL/TNF

    217130140386047227206100111411171520598078340

    NDKcontrol extmediumCape/NDKCape/control extCape/mediumGenistein/NDKGenistein/control extGenistein/mediumPD 98/NDKPD98/control extPD 98/mediumAG18/NDKAG18/control extAG18/mediump38/NDKp38/control extp38/mediumIL/TNF

    2381521381.51.34635204417.5232580122104173193227340

    mouse and inhibitors

    217.5

    130

    140

    SB190

    38

    60

    47

    SB580

    59

    80

    78

    Calphostin

    227

    206

    100

    JNK

    11

    14

    11

    PDTC

    17

    15

    20

    SQ

    130

    170

    144

    Pertusis toxin

    236

    225

    205

    PD 98

    17.5

    23

    25

    AG18

    80

    122

    104

    P38

    173

    193

    227

    MFA

    cell extract

    Relative Luciferase Activity [RLA]

    Effect of signal transduction inhibitors on C3 promoter induction by HIV in primary mouse astrocytes

    Sheet10

    NDK217.5

    c.ext130

    medium140

    SB190

    + NDK38

    c.ext60

    medium47

    SB580

    + NDK59

    c.ext80

    medium78

    Calphostin

    + NDK227

    c.ext206

    medium100

    JNK

    + NDK11

    c.ext14

    medium11

    PDTC

    + NDK17

    c.ext15

    medium20

    SQ

    + NDK130

    c.ext170

    medium144

    Pertusis toxin

    + NDK236

    c.ext225

    medium205

    PD 98

    + NDK17.5

    c.ext23

    medium25

    AG18

    + NDK80

    c.ext122

    medium104

    P38

    + NDK173

    c.ext193

    medium227

    gene expr 7 days

    37.6

    3378.5

    1

    0.84

    7 days

    cell extract

    Fold change

    C 3 gene expression in HFA by HIV

    Sheet9

    MVP[5pgP24/cellIL1-beta[10ng/ml]control extractmedium

    37.63378.510.84

    MVP[5pgP24/cell]IL1-beta[10ng/ml]control extractmedium

    8.6812.310.6

    Sheet8

    1.0430.1891.0150.545

    C3 gene exp 7days

    4.84

    37.6

    1

    376.7

    3378.6

    7 days

    cell extract

    fold change

    C3 gene expression by HIV {MVP} in HFA on 7 days of infection

    Sheet7

    7days

    MVP [J]1pg5pgc.extTNFIL1

    4.8437.61376.73378.6

    Sheet4

    12negative16020U/ml13720ng/ml138

    10720012610U/ml11910ng/ml119

    601001250.2U/ml1382ng/ml137

    5650

    Sheet4

    0

    0

    0

    0

    -/+HIV

    Ratio pGLC3pro/RLTK

    Induction of C3 promoter by HIV dose dependent

    C3 gene expr march24

    0

    0

    0

    Jim's stock

    Il 1-beta [U/ml]

    Ratio pGLC3 pro/RLTK

    Influence of IL1-beta on C3 induction promoter

    Sheet13

    0

    0

    0

    New Il1-beta

    IL1-beta [ng/ml]

    Ratio pGLC3pro/RLTK

    Influence of Il1-beta on C3 induction promoter

    p50 NFkB BR37

    1.68

    2.82

    2.44

    3.67

    1

    1.04

    24h

    Cell extract

    Fold change

    C3 gene expresion in HFA by HIV

    p50-p65p

    Panomic dec12

    0

    00.2

    00.3

    00.35

    00.53

    00.027

    00.024

    00.545

    0-0.01

    cell extract

    OD [p50-p65]

    Detection of p50 subunits of heterodimer p50-p65 NFkB in HFA after HIV infection

    Sheet12

    0.2

    0.3

    0.35

    0.53

    0.027

    0.024

    0.545

    -0.01

    OD [NFkBp50]

    Sheet6

    0.20.0529150262

    0.30.05

    0.350.0264575131

    0.530.0057735027

    0.0270.001

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    **

    ***

    ****

    ****

    ****

    cell extract

    OD [NFkB subunit p50]

    Sheet5

    HIV [2pg]HIV [4pg]TNF[10U/ml]IL-1[5ng/ml]control extmediumpositive controlcompetition control

    av0.20.30.350.530.0270.0240.545-0.01

    0.30.40.40.530.0260.0230.54-0.01

    0.280.350.390.520.0250.0240.542-0.011

    av0.260.350.380.52666666670.0260.02366666670.5423333333-0.0103333333

    SD0.05291502620.050.02645751310.00577350270.0010.00057735030.00251661150.0005773503

    Ttest0.00156259920.00035917490.00002060.00000000.00000000.0000007

    NDK

    Sheet3

    NDK fNDK nNL4-3 fIL/TNFc.ext 10ulmedium

    1.682.822.443.6711.04

    3.63.491

    1.60.7614

    5081

    67120

    6040

    116.665

    67.7

    0

    0

    0

    0

    0

    0

    0

    Cape exp

    inhibitor/+-IL1beta/+-HIV

    Ratio pGLC3pro/RLTK

    CAPE/+-HIV/+-IL1beta

    0

    0

    0

    0

    0

    0

    GENISTEIN exp

    inhibitor/+-HIV/+_ IL1-beta

    RATIO pGLC3pro/RLTK

    GENISTEIN/+-HIV/+_IL1-beta

    0

    0

    Controls- HFA brain28/3 infection NL4-3/PBL

    HIV/-HIV

    RATIO pGLC3pro/RLTK

    149

    2430

    148.5184.4

    119.25210.25

    81153

    52.2573.33

    120206.66

    14.6616.33

    2741

    96152.33

    59.33125.33

    71.6670

    00

    2438

    00

    00

    00

    00

    00

    00

    00

    Ratio

    Effect of HIV on the activity of different C3 promoter constructs in HFA

    00

    00

    00

    00

    00

    00

    00

    Ratio

    Effect of HIV on the activity of different C3 promoter constructs in HFA [systemA/2]

    MBD0003B060.doc

    MBD000020EA.xls

    C3protein wykres or

    141.66512.667.66.4

    108.66457.73.28.4

    10.3387.331.043.2

    19.16191.6626.3

    20.762371.0712.5

    0.311.533

    0.2410.5

    C

    3d

    7d

    supernatants

    C3 Protein [ng/ml]

    inhibitors 2b graph

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    graph cont inhib 2b

    1577.9917269723

    62.52

    113.6055512755

    150.2385979883

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    kontrole do inhib 2b

    HIVmedmock cIL-1TNF-mediummock c

    average31111515762.51115

    25.51316156.5551316

    40.011118158.170.531118

    26.95911156.461.97911

    average30.82111515762.51115

    SD7.991726972323.60555127550.95393920147.778553850223.6055512755

    Ttest0.03534436910.00000031680.0006591335

    IL-1 betaTNF-alfamediummock

    15762.51115

    156.5551316

    158.170.531118

    156.461.97911

    av15762.51115

    SD0.95393920147.778553850223.6055512755

    0.0006591335

    inhibitors2b

    HIVIL-1 betaTNF- alfamediummockCape/HIVCape/mediumPDTC/HIVPDTC/mediumAG18/HIVAG18/mediumU126/HIVU126/mediumWortmanin/HIVWortmanin/mediumSQ-22536/HIVSQ-22536/mediumCalphostin/HIVCalphostin/medium

    3115762.5111533.61311.51111.43733382137.6302825

    7.99172697230.95393920147.778553850223.60555127550.23859798830.35694257240.16165807540.50.88573886292.11660104890.71103650870.41508031355.36055967230.86694867214.89672339434.43030472996.55743852432.6457513111

    19-Jul

    HIVmediummockCape/HIVCape/mediumPDTC/HIVPDTC/mediumAG18/HIVAG18/mediumU126/HIVU126/mediumCalphostin/HIVCalphostin/medium

    av31111533.61311.51111.437332825

    SD7.991726972323.60555127550.23859798830.35694257240.16165807540.50.88573886292.11660104890.71103650870.41508031356.55743852432.6457513111

    controle do graph inhib2b wl

    controle do graph inhib2b wl

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wl graph 1 Elisa p50NFkB

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    graphknock 5000vpC3 prom

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    wl graph ad 5000 C3 prom bz Il1

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    daneknockout 5000vp promotor C3

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    1 EL p50NFkB

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    EL p50 controls

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    mC3RNA 24h, 3d signal transd

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    inhib2A wlasc grapg bez Il1

    317.9917269723

    112

    153.6055512755

    30.2385979883

    3.60.3569425724

    130.1616580754

    11.50.5

    110.8857388629

    11.42.1166010489

    370.7110365087

    330.4150803135

    286.5574385243

    252.6457513111

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    graph Inhib 2A bez Il1

    1570.9539392014

    62.57.7785538502

    112

    153.6055512755

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    C3 protein wykres

    C3 protein wykres

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    inhibitors 2A

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    C3 proteimna graph or

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    C3 proteina

    C3 proteina

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    1NFkB ELISA

    471.5275252317

    242.5166114784

    221.443375673

    4.90.1527525232

    6.20.2645751311

    4.250.2306512519

    38.31.5275252317

    7.10.3511884584

    6.90.2

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    Exp 02/05Ad 5000vp/cellAd-IkB/mockAd-IkB/HIV

    Br52/2Adenovirus-IkB

    systemHIV+mockmediumAdenovirus-IkBAd-IkB/mockAd-IkB/HIVAdenovirusAd/mockAd/HIV+

    average4724224.256.24.96.97.138.3

    14822213.946.64.76.57.236

    2491918.54.46.14.96.36.837

    34624214.26.54.66.16.539

    average47.522.2520.6254.186.44.73333333336.36.833333333337.3333333333

    SD1.52752523172.51661147841.4433756730.23065125190.26457513110.15275252320.20.35118845841.5275252317

    Br52/2

    systemHIV+mockmediumAd-IkB/HIV+Ad-IkB/mockAd-IkB/mediumAd/HIV+Ad/mockAd-medium

    average4724224.96.24.2538.37.16.9

    14822214.76.63.94367.26.5

    2491918.54.96.14.4376.86.3

    34624214.66.54.2396.56.1

    average47.522.2520.6254.73333333336.44.1837.33333333336.83333333336.3

    SD1.52752523172.51661147841.4433756730.15275252320.26457513110.23065125191.52752523170.35118845840.2

    0.280.0115470054

    0.370.0251661148

    0.40.0057735027

    0.530.0057735027

    0.0260.0005773503

    0.0240.0005773503

    0.5450.0025166115

    -0.010.0005773503

    30min

    nuclear extract

    OD value [450nm]

    systemcontrol+Competition cIL-1 betaIL-6HIV+mockmedium

    average0.2170.0330.2040.1240.1560.0620.047

    10.2170.2170.1240.160.060.047

    20.2140.0360.2080.1210.150.0610.044

    30.220.0330.2040.1250.1620.0640.049

    average0.2170.03450.20966666670.12333333330.15733333330.06166666670.0466666667

    SD0.0030.00212132030.00665832810.0020816660.00642910050.0020816660.0025166115

    HIV [2pg]HIV [4pg]TNF[10U/ml]IL-1[5ng/ml]control extmediumpositive controlcompetition control

    av0.20.30.350.530.0270.0240.545-0.01

    0.30.40.40.530.0260.0230.54-0.01

    0.280.350.390.520.0250.0240.542-0.011

    av0.260.350.380.52666666670.0260.02366666670.5423333333-0.0103333333

    SD0.05291502620.050.02645751310.00577350270.0010.00057735030.00251661150.0005773503

    Ttest0.00156259920.00035917490.00002060.00000000.00000000.0000007

    HIV [1pg]HIV [2.5pg]TNF-alfaIL-1 betamockmediumpositive controlcompetition control

    av0.280.370.40.530.0260.0240.545-0.01

    0.30.40.40.530.0260.0230.54-0.01

    0.280.350.390.520.0250.0240.542-0.011

    av0.28666666670.37333333330.39666666670.52666666670.02566666670.02366666670.5423333333-0.0103333333

    SD0.01154700540.02516611480.00577350270.00577350270.00057735030.00057735030.00251661150.0005773503

    Ttest0.00000255570.00001811070.00000000.00000000.00000000.0000002

    cell signalling involved in the activation of C3 gene expression

    HIVmockmediumCape/HIVCape/mockCape/mediumGenistein/HIVGenistein/mockGenistein/mediumAG17/HIVAG17/mockAG17/medium

    24h1410.672.90.580.4931.170.96.30.630.69

    13.70.90.592.40.550.512.61.280.85.80.90.77

    15.21.10.712.20.610.522.91.41.15.70.860.82

    av14.310.65666666672.50.580.50666666672.83333333331.28333333330.93333333335.93333333330.79666666670.76

    SD0.79372539330.10.06110100930.36055512750.030.01527525230.20816659990.11503622620.15275252320.32145502540.145716620.0655743852

    test

    3d15.540.6560.783.50.40.93.12.11.86.70.780.5

    16.40.70.793.40.520.913.22.21.66.40.980.6

    16.30.630.822.950.490.893.52.31.56.20.890.67

    av16.080.6620.79666666673.28333333330.470.93.26666666672.21.63333333336.43333333330.88333333330.59

    SD0.47031904070.0353836120.020816660.29297326390.062449980.010.20816659990.10.15275252320.25166114780.1001665280.0854400375

    SD

    HIVmockmediumCape/HIVCape/mockCape/mediumGenistein/HIVGenistein/mockGenistein/mediumAG17/HIVAG17/mockAG17/medium

    24h14.310.65666666672.50.580.50666666672.83333333331.28333333330.93333333335.93333333330.79666666670.76

    3d16.080.6620.79666666673.28333333330.470.93.26666666672.21.63333333336.43333333330.88333333330.59

    SD240.79372539330.10.06110100930.36055512750.030.01527525230.20816659990.11503622620.15275252320.32145502540.145716620.0655743852

    SD3d0.47031904070.0353836120.020816660.29297326390.062449980.010.20816659990.10.15275252320.25166114780.1001665280.0854400375

    14.316.08350.79372539330.47031904071

    10.6620.93333333330.10.0353836120.1527525232

    0.65666666670.79666666670.96333333330.06110100930.020816660.118462371

    2.53.28333333333.33333333330.36055512750.29297326390.4509249753

    0.580.470.75666666670.030.062449980.0585946528

    0.50666666670.90.80.01527525230.010.1

    2.83333333333.26666666674.10.20816659990.20816659990.1732050808

    1.28333333332.22.46666666670.11503622620.10.2516611478

    0.93333333331.63333333332.09333333330.15275252320.15275252320.1101514109

    5.93333333336.433333333311.40.32145502540.25166114781.1532562595

    0.79666666670.88333333330.91333333330.145716620.1001665282.74

    0.760.590.13233333330.06557438520.08544003750.0924463809

    24h

    3d

    7d

    cell extract

    Relative quantification; Fold change

    Cell signalling involved in the activation of C3 gene expression

    0.79372539330.4703190407

    0.10.035383612

    0.06110100930.02081666

    0.36055512750.2929732639

    0.030.06244998

    0.01527525230.01

    0.20816659990.2081665999

    0.11503622620.1

    0.15275252320.1527525232

    0.32145502540.2516611478

    0.145716620.100166528

    0.06557438520.0854400375

    24h

    3d

    cell extract

    Fold change [C3 mRNA]

    135.33333333336.1101009266

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Re;ative Luciferase Activity [RLU]

    135.33333333336.1101009266

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Re;ative Luciferase Activity [RLU]

    141.66512.66

    108.66457.7

    10.3387.33

    19.16191.66

    20.76237

    0.311.5

    0.2410.5

    3d

    7d

    supernatants

    C3 Protein [ng/ml]

    141.66512.667.66.4

    108.66457.73.28.4

    10.3387.331.043.2

    19.16191.6626.3

    20.762371.0712.5

    0.311.533

    0.2410.5

    C

    3d

    7d

    supernatants

    C3 Protein [ng/ml]

    HIVmockmediumCape/HIVCape/mockCape/mediumP38/HIVP38/mockP38/mediumSB580/HIVSB580/mockSB580/mediumSB190/HIVSB190/mockSB580/mediumAG17/HIVAG17/mockAG17/mediumJNK/HIVJNK/mockJNK/mediumGenistein/HIVGenistein/mockGenistein/medium

    135.33333333336566.33333333335.56666666675.55.5333333333100.333333333311185.333333333333.333333333337.666666666733.33333333332121.666666666721.666666666753.666666666751.66666666674965.666666666747.3333333333493.66666666675.33333333333.6666666667Average

    6.11010092664.35889894351.52752523170.51316014390.50.923760430717.6162803498.18535277198.96288643984.93288286238.504900548110.40832999734.35889894358.96288643988.08290376875.50757054736.65832811855.291502622111.01514109462.51661147842.64575131110.57735026920.57735026920.5773502692SD

    0.00008431090.00001958870.00001947480.00002075310.02798383280.00100840240.024151360.00113383070.00774020590.00827556490.00024601170.00122031550.04907193280.01557401090.00690512192.51661147840.0055620.00001740970.00001942550.0000174097Ttest

    135.33333333336.1101009266

    37916.8226038413

    654.3588989435

    66.33333333331.5275252317

    5.56666666670.5131601439

    5.50.5

    5.53333333330.9237604307

    100.333333333317.616280349

    1118.1853527719

    85.33333333338.9628864398

    33.33333333334.9328828623

    37.66666666678.5049005481

    33.333333333310.4083299973

    214.3588989435

    21.66666666678.9628864398

    21.66666666678.0829037687

    53.66666666675.5075705473

    51.66666666676.6583281185

    495.2915026221

    65.666666666711.0151410946

    47.33333333332.5166114784

    492.6457513111

    3.66666666670.5773502692

    5.33333333330.5773502692

    3.66666666670.5773502692

    48h

    cell extract

    Relative Luciferase Activity [RLU]

    141.66512.66

    108.66457.7

    10.3387.33

    19.16191.66

    20.76237

    0.311.5

    0.2410.5

    3d

    7d

    supernatants

    C3 Protein [ng/ml]

    PROTEINAVERAGESD

    IL-1141.66666677.637626158

    TNF-alfa108.66666673.214550254

    HIV [0.5]10.333333331.040833

    HIV [1pg]19.166666672.020725942

    HIV [2.5pg]20.766666671.078579312

    mock0.30.2

    medium0.2433333330.049328829

    IL-1512.66666676.429100507

    TNF-alfa457.76666678.494900431

    HIV [0.5]87.333333333.214550254

    HIV [1pg]191.66333336.345079458

    HIV [2.5pg]236.666666712.58305739

    mock3.510.5

    medium30.1

    IL-1 betaTNF-alfaHIV [0.5pg]HIV [1pg]HIV [2.5pg]mockmedium

    AV3d141.66108.6610.3319.1620.760.30.24

    Av7d512.66457.787.33191.6623711.510.5

    SD3d7.633.21.042.021.070.20.04

    SD7d6.428.43.26.312.53.52

    HIV [1pg]HIV [2.5pg]TNF-alfaIL-1 betamockmediumpositive controlcompetition control

    0.20.30.350.530.0270.0240.545-0.01

    0.220.320.360.550.0230.0220.546-0.011

    0.210.330.3670.60.0210.0230.546-0.012

    av

    SD

    MBD0009EEC5.xls

    22,3

    53

    24

    50

    5.65

    2.5

    1.4

    0.5

    25

    22

    22.5

    1-control(+)HIV, 2-Control(-)HIV, 3-Calphostin-C, 4-SQ22536, 5-CAPE 1:10000, 6-CAPE 1:15000, 7-Genistein 1:1000, 8-Genistein 1:2000, 9-PMA, 10-Pertusis toxin, 11-8Br-cAMP

    inhibitors

    RATIO pGLC3pro/pRLTK dual luciferase assay

    Br22/3 C3 PROMOTER INDUCTION by HIV with INHIBITORS

    22,3+-

    5312

    2421

    5033

    5.654.5

    2.54.6

    1.40.98

    0.50.4

    2522

    2215

    22.515

    contr(+)/(-)

    Calph

    SQ22536

    CAPE:10000

    CAPE;15000

    Genist:1000

    Genist:2000

    PMA

    Pertusis toxin

    8Br-cAMP

    +HIV

    -HIV

    inhibitors with/w-o HIV

    RATIO pGLC3pro/pRLTK Dual Luciferase Assay

    BRAIN 22/3

    Sheet1

    5312

    2421

    5033

    5.654.5

    2.54.6

    1.40.98

    0.50.4

    2522

    2215

    22.515

    Sheet1

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    0

    inhibitors(-)HIV

    inhibitors

    Ratio pGlC3/pRLTH

    C3 induction promoter - inhibitors without HIV

    Br22,4

    Br22,4

    49

    25

    16.5

    44

    18

    7.6

    4.7

    1.2

    20

    22

    31.4

    35

    Br22/4 inhibitors (+) HIV

    inhibitors

    Ratio pGL3C/pRLTK

    -

    20

    22.5

    30

    33.5

    11

    9.7

    1.3

    3.4

    20

    20

    32

    25

    inhibitors(+) HIV

    inhibitors

    Ratio pGLC3/pRLTK Dual-Luciferase Assay

    BR 22/4 C3 induction promoter

    49

    25

    16.5

    44

    18

    7.6

    4.7

    1.2

    20

    22

    31.4

    35

    inhibitors (-) HIV

    18,4

    50

    46

    26

    42

    18.4

    126

    84

    72.5

    75.6

    inhibitors (+) HIV

    inhibitors

    Ratio pGLC3/pRLTK

    Br 18/5 C3 induction promoter

    18,4 bez HIV

    23

    42

    35

    56

    16

    72

    45

    80

    38

    inhibitors (-) HIV

    br4p4

    4920

    2522.5

    16.530

    4433.5

    1811

    7.69.7

    4.71.3

    1.23.4

    2020

    2220

    31.432

    3525

    control(+)/(-)

    Calph:1000

    Calph10-5

    SQ22536

    CAPE:20000

    CAPE:15000

    Genist:2000

    Genist:1000

    8-Br-cAMP(1pgHIV)

    PMA(1pgHIV)

    Pertusis t1x

    Pertusis t5x

    (+)HIV

    (-)HIV

    inhibitors with/w-o HIV

    RATIO pGLC3pro/pRLTK

    Brain 22/4

    C 3 promoter induction March06

    7.5

    4.5

    2.5

    3.8

    1

    cell extract

    Fold change [Relative Luciferase Unit

    C3 promoter induction by HIV in HFA

    MVP and C3promoter

    7.5

    4.5

    2.5

    3.8

    1

    cell extract

    Fold change [Luciferase Activity Unit]

    C3 promoter induction by HIV[MVP] in HFA

    Sheet14

    IL1-beta